DK1165100T3 - Fremgangsmåder til behandling af skizofreni - Google Patents
Fremgangsmåder til behandling af skizofreniInfo
- Publication number
- DK1165100T3 DK1165100T3 DK00918222T DK00918222T DK1165100T3 DK 1165100 T3 DK1165100 T3 DK 1165100T3 DK 00918222 T DK00918222 T DK 00918222T DK 00918222 T DK00918222 T DK 00918222T DK 1165100 T3 DK1165100 T3 DK 1165100T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- schizophrenia
- therapeutic cells
- treatment
- eps
- Prior art date
Links
- 201000000980 schizophrenia Diseases 0.000 title abstract 3
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 4
- 230000001225 therapeutic effect Effects 0.000 abstract 4
- 229960003638 dopamine Drugs 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
- 102000007072 Nerve Growth Factors Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003900 neurotrophic factor Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Telephonic Communication Services (AREA)
- Discharging, Photosensitive Material Shape In Electrophotography (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/289,576 US7115256B1 (en) | 1999-04-09 | 1999-04-09 | Methods of treating schizophrenia |
| PCT/US2000/007514 WO2000061156A2 (en) | 1999-04-09 | 2000-03-20 | Methods of treating schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1165100T3 true DK1165100T3 (da) | 2007-05-07 |
Family
ID=23112130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00918222T DK1165100T3 (da) | 1999-04-09 | 2000-03-20 | Fremgangsmåder til behandling af skizofreni |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7115256B1 (de) |
| EP (1) | EP1165100B1 (de) |
| JP (1) | JP2003532621A (de) |
| AT (1) | ATE349218T1 (de) |
| AU (1) | AU778494B2 (de) |
| CA (1) | CA2369439A1 (de) |
| CY (1) | CY1106371T1 (de) |
| DE (1) | DE60032590T2 (de) |
| DK (1) | DK1165100T3 (de) |
| ES (1) | ES2275501T3 (de) |
| HK (1) | HK1040054B (de) |
| IL (3) | IL145815A0 (de) |
| MX (1) | MXPA01010131A (de) |
| NO (1) | NO20014890L (de) |
| NZ (1) | NZ514652A (de) |
| PT (1) | PT1165100E (de) |
| WO (1) | WO2000061156A2 (de) |
| ZA (1) | ZA200108251B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115256B1 (en) * | 1999-04-09 | 2006-10-03 | Titan Pharmaceuticals, Inc. | Methods of treating schizophrenia |
| DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
| EP1642586A4 (de) * | 2003-06-06 | 2009-06-17 | Kringle Pharma Inc | Zellhaltige zubereitungen |
| US20070065422A1 (en) * | 2005-09-20 | 2007-03-22 | Cameron Don F | Induction of immune tolerance by sertoli cells |
| US7940978B2 (en) * | 2007-06-05 | 2011-05-10 | General Electric Company | Automatic characterization of cellular motion |
| US20090035370A1 (en) * | 2007-08-02 | 2009-02-05 | Drugtech Corporation | Dosage form and method of use |
| US20100060713A1 (en) * | 2008-09-10 | 2010-03-11 | Eastman Kodak Company | System and Method for Enhancing Noverbal Aspects of Communication |
| KR20120007139A (ko) * | 2010-07-14 | 2012-01-20 | 주식회사 파미니티 | 탄소나노튜브를 유효성분으로 함유하는 뇌질환 예방 또는 치료용 조성물 |
| WO2014128882A1 (ja) * | 2013-02-21 | 2014-08-28 | 医療法人 和楽会 | 不安うつ病の治療薬 |
| US11690876B2 (en) | 2017-05-10 | 2023-07-04 | University Of Rochester | Methods of treating neuropsychiatric disorders |
| MX2020012459A (es) | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
| EP3803866A4 (de) | 2018-05-24 | 2022-03-16 | Nureva Inc. | Verfahren, vorrichtung und computerlesbare medien zur verwaltung halbkonstanter (persistenter) schallquellen in mikrofonaufnahme-/-fokuszonen |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE464816B (sv) | 1985-10-15 | 1991-06-17 | Nilsson Kjell | Makroporoesa partiklar, foerfarande foer dess framstaellning och dess anvaendning |
| US5650148A (en) | 1988-12-15 | 1997-07-22 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
| US5447948A (en) | 1992-05-07 | 1995-09-05 | Yale University | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia |
| DK0755258T3 (da) | 1994-04-13 | 2002-05-13 | Res Corp Technologies Inc | Fremgangsmåde til behandling af sygdom ved at anvende Sertoli-celler og allo-transplantater eller xeno-transplantater |
| AU7963998A (en) | 1997-06-13 | 1998-12-30 | University Technology Corporation | Transplantation of immortalized dopamine cells to improve neurological deficits |
| EP1044024A1 (de) | 1998-01-02 | 2000-10-18 | Titan Pharmaceuticals, Inc. | Verwendung pigmentierter retinaler epithelzellen zur schaffung eines immunpriviligierten ortes |
| US7115256B1 (en) * | 1999-04-09 | 2006-10-03 | Titan Pharmaceuticals, Inc. | Methods of treating schizophrenia |
-
1999
- 1999-04-09 US US09/289,576 patent/US7115256B1/en not_active Expired - Fee Related
-
2000
- 2000-03-20 EP EP00918222A patent/EP1165100B1/de not_active Expired - Lifetime
- 2000-03-20 MX MXPA01010131A patent/MXPA01010131A/es active IP Right Grant
- 2000-03-20 WO PCT/US2000/007514 patent/WO2000061156A2/en not_active Ceased
- 2000-03-20 IL IL14581500A patent/IL145815A0/xx unknown
- 2000-03-20 DE DE60032590T patent/DE60032590T2/de not_active Expired - Fee Related
- 2000-03-20 CA CA002369439A patent/CA2369439A1/en not_active Abandoned
- 2000-03-20 AU AU39071/00A patent/AU778494B2/en not_active Ceased
- 2000-03-20 HK HK02101493.8A patent/HK1040054B/en not_active IP Right Cessation
- 2000-03-20 AT AT00918222T patent/ATE349218T1/de not_active IP Right Cessation
- 2000-03-20 PT PT00918222T patent/PT1165100E/pt unknown
- 2000-03-20 DK DK00918222T patent/DK1165100T3/da active
- 2000-03-20 JP JP2000610489A patent/JP2003532621A/ja active Pending
- 2000-03-20 ES ES00918222T patent/ES2275501T3/es not_active Expired - Lifetime
- 2000-03-20 NZ NZ514652A patent/NZ514652A/en unknown
-
2001
- 2001-10-07 IL IL145815A patent/IL145815A/en active IP Right Grant
- 2001-10-08 NO NO20014890A patent/NO20014890L/no not_active Application Discontinuation
- 2001-10-08 ZA ZA200108251A patent/ZA200108251B/xx unknown
-
2006
- 2006-08-01 US US11/497,914 patent/US20060292128A1/en not_active Abandoned
- 2006-08-17 IL IL177538A patent/IL177538A0/en unknown
-
2007
- 2007-03-13 CY CY20071100344T patent/CY1106371T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL177538A0 (en) | 2006-12-10 |
| EP1165100B1 (de) | 2006-12-27 |
| CA2369439A1 (en) | 2000-10-19 |
| IL145815A (en) | 2008-12-29 |
| NO20014890D0 (no) | 2001-10-08 |
| ES2275501T3 (es) | 2007-06-16 |
| JP2003532621A (ja) | 2003-11-05 |
| WO2000061156A2 (en) | 2000-10-19 |
| PT1165100E (pt) | 2007-02-28 |
| US7115256B1 (en) | 2006-10-03 |
| AU3907100A (en) | 2000-11-14 |
| NZ514652A (en) | 2004-06-25 |
| CY1106371T1 (el) | 2011-10-12 |
| HK1040054A1 (en) | 2002-05-24 |
| IL145815A0 (en) | 2002-07-25 |
| AU778494B2 (en) | 2004-12-09 |
| MXPA01010131A (es) | 2002-08-20 |
| DE60032590T2 (de) | 2007-10-11 |
| EP1165100A2 (de) | 2002-01-02 |
| HK1040054B (en) | 2007-08-10 |
| NO20014890L (no) | 2001-12-05 |
| WO2000061156A3 (en) | 2001-01-25 |
| DE60032590D1 (de) | 2007-02-08 |
| ZA200108251B (en) | 2002-12-24 |
| US20060292128A1 (en) | 2006-12-28 |
| ATE349218T1 (de) | 2007-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106371T1 (el) | Μεθοδοι αγωγης της σχιζοφρενειας | |
| CL2007001733A1 (es) | Compuestos derivados de imidazol condensado con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras. | |
| CL2009000380A1 (es) | Compuestos derivados de heterociclos, moduladores de beta-amiloide; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la enfermedad de alzheimer, angioplastia cerebral amiloide, demencia multiinfarto, sindrome de down, entre otras. | |
| CL2007001734A1 (es) | Compuestos derivados de imidazol condensados con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras. | |
| MY159955A (en) | Certain chemical entities, compositions and methods | |
| NO20013444D0 (no) | Triazolforbindelser med dopamin-D3-reseptor-affinet | |
| DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| NO20072984L (no) | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment | |
| TW200720268A (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors | |
| CL2007001732A1 (es) | Compuestos derivados de imidazo[1,5-a]pirimidina; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras. | |
| MX2010002319A (es) | Derivados indolicos 2,3 sustituidos para el tratamiento de infecciones virales. | |
| BRPI0418112A (pt) | inibidores de p-38 quinase bicìclico heterocìclicos | |
| CL2007002635A1 (es) | Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion. | |
| CL2011000838A1 (es) | Compuestos heterociclicos derivados de tetraciclos ortocondensados con un grupo pirimidina 2,4,6-triona espirocondensado, inhibidores de la adn girasa bacteriana; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana. | |
| CL2011001098A1 (es) | Compuestos derivados de 4-fluoro-1h-isoindol-3-amina; inhibidores de b-secretasa (bace); composicion farmaceutica; y su uso para el tratamiento o prevencion de una patologia relacionada con la proteina beta amiloide tal como sindrome de down, alzheimer, demencia senil y demencia asociada con parkinson, entre otras. | |
| DE60323133D1 (de) | Cyclohexylverbindungen als ccr5-antagonisten | |
| NO20074207L (no) | Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| TNSN07240A1 (en) | Compounds for flaviviridae treatment | |
| DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
| DK0556332T3 (da) | Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet | |
| ATE534652T1 (de) | Phosphono-pent-2-en-1-yl-nukleoside und analoga | |
| PL1663347T3 (pl) | Urządzenie do rozdzielania elementów krwi | |
| IL174787A0 (en) | Use of cell lines to produce active therapeutic proteins |